Drug Eluting Stent

Related by string. drug eluting stents * Drugs . DRUG . drugs : Drug Task Force . Prescription Drug User Fee . Drug Enforcement Administration / eluted . eluting : CYPHER R Sirolimus eluting . CYPHER ® Sirolimus eluting . Resolute drug eluting / stenting . Stents : drug coated stents . stents inserted * drug eluting stent implantation . Drug Eluting Stent System . drug eluting stent DES *

Related by context. All words. (Click for frequent words.) 77 Drug Eluting Stents 76 Coronary Stent 75 Pivotal Trial 74 TM Drug Eluting 73 Balloon Catheter 72 Drug Eluting 72 Cypher Sirolimus 72 Drug Eluting Coronary Stent 71 Bare Metal Stents 71 Coronary Stent System 71 Pivotal Clinical Trial 71 Clinical Trial Results 71 Completes Enrollment 70 Randomized Clinical Trial 70 Phase III Clinical Trial 70 TAXUS Element Paclitaxel Eluting 70 Expanded Indication 70 Phase III Trial 70 Patients Treated 70 Patient Enrollment 69 PROMUS TM 69 Liberte TM 69 Receives FDA Clearance 69 Stent System 69 FDA Approvals 69 TAXUS ® 69 Pivotal Study 69 Announces FDA Clearance 69 Bare Metal Stent 69 Unfractionated Heparin 68 ® Drug Eluting 68 Pivotal Phase III 68 Endeavor Drug Eluting 68 Study Evaluating 68 Receives CE 68 Eluting Coronary Stent System 68 Meets Primary Endpoint 68 Receives Orphan Drug Designation 68 Improves Survival 68 FDA Clearance 68 CYPHER R Sirolimus Eluting 68 Clinical Trial Evaluating 68 Cardiac Resynchronization Therapy 68 Patients Enrolled 68 Randomized Study 68 PROMUS Element Everolimus Eluting 68 Diabetic Patients 67 Patients Treated With 67 drug eluting coronary stent 67 Obtains CE Mark 67 Survival Benefit 67 PROMUS Element 67 Completes Patient Enrollment 67 ™ Everolimus Eluting 67 Prospective Randomized 67 Endovascular Treatment 67 TM Everolimus Eluting 67 Sirolimus Eluting Coronary Stent 67 stent DES 67 Drug Coated Stent 67 Thrombectomy 67 Adjuvant Treatment 67 PROMUS R 67 Endeavor drug eluting 67 Advanced Colorectal Cancer 67 Sirolimus eluting Coronary Stent 67 Receives Positive Opinion 67 Gets FDA Clearance 67 Carotid 66 Long Term Efficacy 66 TAXUS Express2 66 Drug Eluting Stent System 66 XIENCE V Everolimus Eluting 66 Bioresorbable 66 First Patient Treated 66 Overactive Bladder 66 Patients Undergoing 66 Bone Graft 66 Stent Thrombosis 66 Generic Version 66 PROMUS ® 66 Acute Ischemic Stroke 66 TAXUS TM 66 XIENCE PRIME TM 66 Acute Myocardial Infarction 66 Lung Cancer Trial 66 ™ Paclitaxel Eluting 66 Single Dose 66 Emboshield 66 JAK Inhibitor 66 NDA Submission 66 WallFlex Biliary RX 66 Patient Outcomes 66 Heart Failure Patients 66 Less Invasive 66 Non Invasive 66 XIENCE TM 66 First Patient Dosed 66 Dry Powder Inhaler 66 Renal Cell Carcinoma 66 Sirolimus Eluting Stent 66 Severe Sepsis 66 Eluting Stent 65 Left Atrial Appendage 65 Metastatic Colorectal Cancer 65 Phase III Clinical Trials 65 Phase IIb Trial 65 TAXUS R 65 Stenting 65 Embolic 65 Prolongs Survival 65 Testosterone Gel 65 Carotid Stenting 65 Vascular Closure Device 65 Embolic Protection 65 Phase 2b Clinical Trial 65 Vascular Graft 65 Restenosis 65 Rheumatoid Arthritis Drug 65 FDA Clears 65 CYPHER SELECT TM 65 Cobalt Chromium 65 drug eluting stent DES 65 Pivotal Phase 65 FDA Approval 65 Endurant 65 Aneurysm Repair 65 paclitaxel eluting 65 Pooled Analysis 65 Initiates Clinical 65 Brain Metastases 65 First Patient Enrolled 65 Paclitaxel Eluting Coronary Stent 65 MULTI LINK VISION 65 Taxus Element 65 Clinical Efficacy 65 Osteoporosis Drugs 65 Gout Drug 65 Vascular Grafts 65 Medtronic Endeavor 65 received CE Conformité 65 Files IND 65 Glatiramer Acetate 65 Clinical Study Shows 65 Monotherapy 65 Chronic Hepatitis B 65 Post Operative 65 Everolimus Eluting Coronary Stent 65 Granted Orphan Drug 65 Clinical Outcome 65 Platinum Chromium 64 Phase 2a Clinical Trial 64 Phase IIb Clinical Trial 64 Rheumatoid Arthritis Patients 64 Cholesterol Lowering Drug 64 TAXUS Stent 64 Initiate Clinical Trial 64 Self Expanding Stent 64 Hypertensive Patients 64 Postmenopausal Women 64 Sirolimus eluting 64 Inhaled Insulin 64 Interferon Alpha 64 Transcatheter 64 Anti Tumor Activity 64 carotid stent 64 Cypher Stent 64 Catheter Ablation 64 Enoxaparin 64 Total Knee Arthroplasty 64 Initiates Enrollment 64 Paclitaxel eluting 64 NAVISTAR R 64 Hepatocellular Carcinoma 64 Multicenter Randomized 64 Stent Restenosis 64 Stent Coating 64 Spinal Implant 64 Oral Insulin 64 Patent Covering 64 Demonstrates Positive 64 Fondaparinux 64 Intracranial Aneurysms 64 Bioabsorbable 64 Benign Prostatic Hyperplasia 64 Platinum Chromium Coronary Stent 64 Acute Heart Failure 64 Initiates Phase II 64 Metastatic Melanoma 64 Submits NDA 64 Low Dose 64 mechanical thrombectomy 64 Dynamic Stabilization 64 Investigational Compound 64 Mitral Valve Repair 64 Carotid Stent 64 Non Inferiority 64 Investigational Treatment 64 XIENCE 64 Randomized Clinical Trials 64 Receives Marketing Authorization 64 PROMUS 64 Bioresorbable Vascular Scaffold 64 Ventricular Assist Devices 64 HepaSphere 64 Bivalirudin 64 AMPLATZER R 64 Previously Treated 64 CE Marked 64 Teva Provides Update 64 TAXUS Liberté 64 Microwave Ablation System 64 Percutaneous Coronary Intervention 64 Spinal Fusion 64 Present Preclinical Data 64 Carotid Artery Stenting 64 k Clearance 64 External Defibrillators 64 Subgroup Analysis 64 Intravascular 64 Anticancer Drug 64 Transcatheter Valve 63 Study Showed 63 Mylan Receives Approval 63 Sirolimus Eluting 63 Cordis Cypher 63 Combination Treatment 63 Nitinol Stent 63 Phase III Trials 63 Endometrial Ablation 63 StarClose 63 Neoadjuvant Chemotherapy 63 Myelodysplastic Syndromes 63 Advanced Renal Cell 63 Milestone Payment 63 Demonstrates Significant 63 GORE TAG 63 Cholesterol Drug 63 Absorbable 63 Heart Stents 63 Aortic Valve 63 Radical Prostatectomy 63 Breast Cancer Treatment 63 Annuloplasty 63 Treatment Experienced 63 Statin Therapy 63 Significantly Reduced 63 Beta Blocker 63 R Paclitaxel Eluting 63 II Clinical Trial 63 Dapagliflozin 63 Cardiovascular Events 63 Combination Therapy 63 Kidney Transplant Patients 63 Preclinical Data 63 Coronary Artery Bypass Graft 63 Left Ventricular 63 Pharmacokinetic Study 63 Initiates Phase III 63 Paroxysmal Atrial Fibrillation 63 INFUSE R 63 TAXUS Liberte 63 Migraine Drug 63 Oral Mucositis 63 Embolic Protection Device 63 Positive Opinion 63 ST Elevation Myocardial 63 Clinical Study 63 XIENCE V drug eluting 63 Drug Candidate 63 Improves Outcomes 63 Phase III Pivotal 63 Well Tolerated 63 Artificial Disc 63 Pediatric Patients 63 Minimally Invasive Procedure 63 FDA Accepts 63 Balloon Catheters 63 Estrogen Therapy 63 Vascular Wrap TM 63 Platelet Inhibition 63 Sevelamer 63 Tacrolimus 63 Implantable Device 63 Osteoporosis Drug 63 Sagent Pharmaceuticals Announces 63 Phase 2a Trial 63 Diabetic Nephropathy 63 ORLive Presents 63 Wound Dressing 63 Resistant Hypertension 63 Bazedoxifene 63 IND Application 63 EverFlex 63 Tumor Targeting 63 Medoxomil 63 Electrophysiology Mapping 63 Endovascular Graft 63 Obtains FDA 63 Surgical Mesh 62 Novel Antibiotic 62 Versus Placebo 62 Elderly Patients 62 Mycophenolate Mofetil 62 Abdominal Stent Graft 62 IND Filing 62 Receives Approvable Letter 62 Tissue Repair 62 Recombinant Human 62 TM Paclitaxel Eluting 62 Compression Therapy 62 Osteoporosis Treatment 62 HeartMate R 62 Chronic Hepatitis C 62 Custom NX R 62 Adjuvant Therapy 62 Radiation Dose 62 Proven Effective 62 Prophylactic Treatment 62 Receives Orphan Drug 62 Appears Safe 62 Endoprosthesis 62 PRN FDA Approves 62 everolimus eluting stent 62 Enrolls First 62 Regenerative Cells 62 Biolimus A9 62 Controlled Study 62 Embolic Protection System 62 Epilepsy Drug 62 Investigational Drug 62 Artery Disease 62 Improve Survival 62 Elagolix 62 Valsartan 62 Non Invasive Treatment 62 Advanced Melanoma 62 FDA Okays 62 zotarolimus eluting stent 62 Implantable Cardioverter Defibrillator 62 Newly Diagnosed Multiple Myeloma 62 FDA Approves 62 Previously Untreated 62 WallFlex 62 SpideRX 62 Randomized Double Blind 62 Hip Implants 62 Endeavor Resolute 62 Stent Implantation 62 TAXUS Liberte Long 62 Silicone Breast Implants 62 Kidney Function 62 Antitumor Activity 62 Antimicrobial Coating 62 Infusion Pumps 62 NexStent 62 Microspheres 62 Novacor R 62 Generic Versions 62 Drug Fails 62 Randomized Evaluation 62 Wound Closure 62 BioElectronics Announces 62 Fibrin Sealant 62 fully bioabsorbable 62 TAXUS Express2 Paclitaxel Eluting 62 Pirfenidone 62 Arthritis Drug 62 Clinical Trial 62 Oral Fingolimod 62 ENDEAVOR IV 62 Combination REOLYSIN R 62 Initiates Clinical Trial 62 Resection 62 Improved Survival 62 mm Stent 62 Colorectal Cancer Patients 62 Hernia Repair 62 Pharmaceuticals Initiates 62 eluting coronary stent 62 Hormone Refractory Prostate Cancer 62 Cardiovascular Outcomes 62 Psoriasis Drug 62 Catheters 62 Cancer Treatments 62 Statistically Significant 62 Embolization 62 Breast Cancer Recurrence 62 Image Guided 62 V Everolimus Eluting Coronary 62 AneuRx 62 Clinical Evaluation 62 PROMUS Stent 62 Seasonal Influenza Vaccine 62 Gliadel R 62 Obese Patients 62 Hepatitis B Vaccine 62 Complicated Skin 62 Receives CE Marking 61 Significantly Reduces 61 Treating Heart Failure 61 Randomized Trials 61 Image Guided Surgery 61 Asthma Treatment 61 DosePro TM 61 Insulin Pen 61 Develop Novel 61 Efficacy Trial 61 RNAi Therapeutic 61 Patency 61 Radiofrequency Ablation 61 Pulmonary Arterial Hypertension 61 liver resection surgeries 61 Immunomedics Announces 61 Balloon Angioplasty 61 Prostate Cancer Treatment 61 Sustained Efficacy 61 Nilotinib 61 Blood Thinner 61 GORE TAG ® 61 Phase IIIb 61 PROMUS Element Stent 61 Atom Stent 61 TriActiv R 61 Weight Loss Drug 61 Acute Coronary Syndrome 61 Angiographic 61 Left Atrial 61 Schizophrenia Treatment 61 Achieves Primary Endpoint 61 Prostate Cancer Vaccine 61 Central Venous Catheters 61 Blood Pressure Drug 61 Taxus Liberte 61 Initiate Phase II 61 Molecular Diagnostic Test 61 Hsp# Inhibitor 61 drug eluting coronary stents 61 Talent Abdominal 61 Soft Tissue Sarcoma 61 Disease Progression 61 Medtronic CoreValve 61 Investigational Agent 61 Anemia Drug 61 Secondary Hyperparathyroidism 61 Insulin Pumps 61 sirolimus eluting 61 Trial Evaluating 61 Rotavirus Vaccine 61 Gastric Cancer 61 Dose Ranging Study 61 Renal Function 61 Pivotal Trials 61 Vertebroplasty 61 XIENCE V 61 Critical Limb Ischemia 61 Taro Receives 61 Ovarian Cancer Treatment 61 Thrombectomy System 61 Clinical Trial Data 61 Commences Phase 61 Presents Positive 61 Relapsed Multiple Myeloma 61 Treatment Naïve 61 Presents Preclinical Data 61 Esophageal 61 Phase 2b Study 61 Systemic Delivery 61 Medtronic CoreValve ® 61 REMINDER ORLive Presents 61 Metastatic Prostate Cancer 61 Complete Remission 61 Knee Osteoarthritis 61 Patient Enrolment 61 Dose Escalation 61 Shows Efficacy 61 Fracture Risk 61 drug eluting stent 61 Long Term Outcomes 61 Bucindolol 61 TAXUS Express2 paclitaxel eluting 61 Urinary Incontinence 61 Hip Prosthesis 61 Rivaroxaban 61 Diabetic Foot Ulcers 61 Inhaled Nitric Oxide 61 Erectile Dysfunction Drug 61 TAXUS Element Stent System 61 Confirmatory Phase 61 Tryton Side Branch 61 Venous Thromboembolism 61 Posaconazole 61 Fungal Infections 61 Desvenlafaxine Succinate 61 Receives Milestone Payment 61 NEVO 61 Drug eluting stent 61 Data Suggest 61 Patent Issued 61 Européenne Mark 61 Tezampanel 61 Contrast Agent 61 Commercially Available 61 Ranolazine 61 FDA Panel Recommends 61 Infarct 61 Biliary System 61 Blocked Arteries 61 Total Knee Replacement 61 Blood Glucose Meter 61 Fixed Dose Combination 61 ACE Inhibitors 61 Castration Resistant Prostate Cancer 61 Prostate Cancer Patients 61 Lupus Drug 61 Augment TM 61 Breast Biopsy 61 Tyrosine Kinase Inhibitor 61 Insulin Glargine 61 Smooth Muscle 61 XIENCE PRIME 61 Begins Clinical Trial 61 Thrombus Aspiration 61 STARFlex R 61 Paclitaxel Eluting 61 Anti Tumor 61 Initiates Clinical Trials 61 Dose Finding 60 Surgical Procedures 60 Acute Coronary Syndromes 60 Anticoagulant 60 Randomized Double Blind Placebo 60 Lung Cancer Drug 60 Renal Impairment 60 Aliskiren 60 Antipsychotic 60 Randomized Phase 60 Oral Anticoagulant 60 Intracerebral Hemorrhage 60 Phase 1b Clinical Trial 60 Tablet Formulation 60 Cilostazol 60 Recurrent Glioblastoma 60 Spectrum Pharmaceuticals Announces 60 Adhesion Barrier 60 Percutaneous 60 Treating Chronic 60 Lung Cancer Patients 60 Glaucoma Treatment 60 Treatment Naive 60 Pegylated Liposomal Doxorubicin 60 Adjuvant Chemotherapy 60 Custom NX 60 Phase 2b Trial 60 Xience V 60 Tesamorelin 60 Drug Eluting Balloon 60 Balloon Kyphoplasty 60 TM Embolic Protection 60 Blood Pressure Monitoring 60 PresbyLens ® 60 Contrast Agents 60 Vascular Closure System 60 Bone Grafts 60 Multiple Myeloma Patients 60 Commence Phase 60 Blood Pressure Reduction 60 ZoMaxx 60 everolimus eluting 60 Thyroid Hormone 60 HER2 Positive Breast Cancer 60 Knee Implant 60 Percutaneous Transluminal Coronary Angioplasty 60 BioMatrix 60 Relapsing Multiple Sclerosis 60 Anticoagulation 60 Dual Antiplatelet Therapy 60 Personalized Immunotherapy 60 Heart Transplant Recipients 60 Thrombolysis 60 Axxion TM 60 Renvela ® 60 Minimally Invasive Treatment 60 Cardiovascular Prosthetic Devices 60 Angiox ® 60 Gene Mutation 60 ferumoxytol Injection 60 Microcatheter 60 Femtosecond Laser 60 Intravenous Formulation 60 Lupus Nephritis 60 Topline Results 60 Surgical Sealant 60 Tumor Growth 60 Peripheral Stent 60 Magnetic Nanoparticles 60 Darbepoetin Alfa 60 Chronic Heart Failure 60 Stents 60 Replacement Therapy 60 Anastomosis 60 Showed Significant 60 Abciximab 60 Successfully Treats 60 Cholesterol Drugs 60 Anti Clotting Drug 60 Targeted Therapies 60 Small Molecule 60 Bevacizumab 60 Lymph Node 60 ATS Simulus R 60 ALVESCO ® 60 Novel Protein 60 Prospective Multicenter 60 Cotavance 60 sirolimus eluting stent 60 Synthetic Peptide 60 Glucose Monitoring 60 Treatment Regimen 60 Technological Advances 60 Drug Shows Promise 60 Chronic Constipation 60 Interferon Gamma 60 Peginterferon 60 Myeloma Patients 60 Feasibility Trial 60 Autologous 60 Autologous Stem Cell Transplantation 60 Endovascular System 60 Long Lesion 60 Trobalt 60 Chronic Sinusitis 60 Schizophrenia Drug 60 MR Angiography 60 Emerging Therapies 60 ibuprofen Injection 60 Laryngeal Cancer 60 NICE Recommends 60 comparing XIENCE V 60 Peripheral Arterial 60 Dupuytren Contracture 60 Ureteral 60 Plaque Psoriasis 60 Refractory Angina 60 Pafuramidine 60 Tecnis R 60 Peripheral Artery Disease 60 Initiate Phase 60 Anticancer Activity 60 Intravitreal 60 Randomized Controlled Trials 60 Bone Metastases 60 Acute Myocardial 60 STELARA TM 60 Innate Immune 60 ThromCat 60 Surgery Performed 60 Drug Coated Stents 60 REG1 Anticoagulation System 60 AngioSculpt 60 Insulin Delivery 60 Combination Clinical Trial 60 Thrombus 60 Transdermal Patch 60 Minimally Invasive 60 Adjunctive Therapy 60 Tolerability 60 Valve Replacement 60 Endometrial Cancer 60 Anticancer Agent 60 Drug Absorption 60 Antiplatelet 60 Mg Usa 60 Endurant Stent Graft 60 Extended Release 60 Is Well Tolerated 60 Trauma Fixation 60 Double Blind Placebo 60 Stent Placement 60 Renal Artery 60 Conor CoStar 60 Spinal Disc 60 Ablation 60 Metastatic Renal Cell Carcinoma 60 Perindopril 60 urethral bulking agent 60 Prospective Randomized Trial 60 Novel Inhibitor 60 Treatment Resistant 60 Controlled Trial 60 Aortic Dissection 60 Vitro Diagnostic 60 Initiate Phase III 60 Further Validates 60 Misonix Announces 60 Pulse Oximetry 60 Interferon Alfa 60 Coronary Arteries 59 Therapy Reduces 59 Study Demonstrates 59 Study Shows Significant 59 Lung Cancer Survival 59 Pulmonary Artery 59 Robotic Assisted 59 bioabsorbable stent 59 Endoluminal 59 Inhaled Corticosteroids 59 Percutaneous Tibial Nerve Stimulation 59 Antiepileptic Drug 59 Powerlink XL 59 Stent Grafts 59 Fewer Side Effects 59 TAXUS ATLAS 59 Stem Cell Treatment 59 Wafer polifeprosan 59 VIVUS Announces 59 XIENCE V stent 59 injectable bulking agent 59 Endeavor stent 59 Efficacious 59 Enlarged Prostate 59 Demonstrates Potential 59 CYPHER ® Sirolimus eluting 59 Demonstrates Sustained 59 drug zotarolimus 59 Inhalation Aerosol 59 Dry Powder Inhalers 59 Thrombin 59 Surgical Ablation 59 Novel Oral 59 Hypercholesterolemia 59 R lenalidomide 59 Patients Suffering 59 Receives Fast Track 59 peripheral stent 59 AneuRx AAAdvantage 59 Circulatory Support 59 Guideline Update 59 Chemoradiation 59 Vacuum Assisted Closure 59 Resolute drug eluting 59 Diabetic Neuropathic Pain 59 Biomaterial 59 Ultrasound Imaging 59 Improve Outcomes 59 Antipsychotic Drug 59 CentriMag 59 Palonosetron 59 Imaging Technique 59 Glucose Control 59 Blood Pressure Lowering 59 endoluminal stent graft 59 Acne Drug 59 Abbott XIENCE V 59 Zoledronic Acid 59 Beneficial Effects 59 Confirms Efficacy 59 Carboplatin Paclitaxel 59 Serious Infections 59 Ozarelix 59 Breast Density 59 Injectable 59 Reduces Pain 59 saphenous vein graft 59 TRANSDUR ® 59 ABSORB 59 ARIXTRA R 59 Oxiplex 59 Relapsing Remitting Multiple Sclerosis 59 Proves Effective 59 CUSTOM III 59 Detection Device 59 PDUFA Date 59 Cardiogenic Shock 59 Anti Inflammatory Drug 59 Surgical Procedure 59 Stent 59 Multicenter Study 59 Cutaneous T 59 CYPHER R Sirolimus eluting 59 Resurfacing System 59 Testosterone Patch 59 Freeze Drying 59 Phase IIa Clinical Trial 59 Liver Metastases 59 Treatment Naive Patients 59 ThermoDox R 59 TAXUS Liberte Stent 59 armodafinil Tablets C 59 Plus Ribavirin 59 coronary drug eluting 59 Medtronic Endeavor stent 59 Osteoarthritis Patients 59 vascular stent 59 Unicompartmental Knee 59 IL# PE#QQR 59 Androgen Deprivation Therapy 59 Artificial Pancreas 59 THERMOCOOL R 59 Diabetic Macular Edema 59 #k Clearance 59 LVAS Left Ventricular Assist 59 Study Shows Benefits 59 Coronary Artery 59 Randomized Placebo Controlled Trial 59 Infusion Pump 59 Augment ™ 59 eluting stent 59 Safinamide 59 REPRONEX R menotropins 59 Renal Cancer 59 Randomized Phase II 59 Ischemic Stroke 59 Romiplostim 59 Male Contraceptive 59 Heparin Bioactive Surface 59 Anticoagulants 59 Metricath Gemini 59 Vaccine Adjuvants 59 Announce License Agreement 59 drug eluting balloons 59 Node Positive 59 Fixed Dose 59 Marketing Authorisation Application 59 Advanced Prostate Cancer 59 Announces Tentative Approval 59 SYNERGY Stent 59 Myocardial Perfusion Imaging 59 Hormone Therapy 59 Ovarian Cancer Patients 59 Bone Mineral Density 59 GATTEX TM 59 Ondansetron Injection USP 59 Anterior Cervical 59 Atherectomy 59 Commercialize 59 SYCREST 59 JAK2 Inhibitor 59 Breast Cancer Patients 59 Endoscope 59 Vertebral Compression Fractures 59 CCX# B 59 Successfully Completes Phase 59 Generic Version Of 59 Multicenter 59 platinum chromium alloy 59 Reduces Mortality 59 MitraClip R 59 ST Segment Elevation 59 Inhalation Solution 59 Fully Covered Stent 59 HER2 Positive 59 Hematological Cancers 59 Levoleucovorin 59 Raptiva R 59 Vildagliptin 59 Express2 TM paclitaxel eluting 59 FOLOTYN ® 59 Effective Than 59 Premenopausal Women 59 Sapacitabine 59 Increased Mortality 59 Fluconazole 59 SPIRIT III 59 Significantly Improved 59 Transdermal Delivery 59 Enrolling Patients 59 TRANSDUR ™ 59 Dendritic Cells 59 Hormone Receptor Positive 59 Antitumor 59 Breast Tumors 59 Thoracic Stent Graft 59 Implantable Defibrillator 59 Laboratory Glassware 59 Pivotal Phase II 59 Amrubicin 59 Eluting 59 DUROLANE 59 Heartburn Drugs 59 Zorbtive TM 59 Vascular Stent 59 Virtual Colonoscopy 59 Orphan Status 59 multicenter multinational 59 Aloxi ® 59 antiplatelet agent 59 Begins Shipment 59 Zilver PTX 59 Ozurdex 59 Stenosis 59 Dialysis Patients 59 Peripheral Arterial Disease 59 Hepatitis C Patients 59 microcatheter 59 Pharos Vitesse 59 FDA Orphan Drug 59 Emboli Capture Guidewire 59 ENLIGHT 59 Oral Calcitonin 58 Lenalidomide 58 GORE TAG Device 58 replacement PAVR 58 Lipid Levels 58 Predict Risk 58 Hip Resurfacing 58 NTIOL 58 Monoclonal Antibody 58 Anti Angiogenic 58 Gastrointestinal Disorders 58 drug eluting balloon 58 Stakeholder Opinions 58 Cetrorelix 58 Contrast Enhanced 58 Epilepsy Drugs 58 AnaSpec Introduces 58 Gene Expression Analysis 58 induced macular edema 58 Factor Xa Inhibitor 58 MGuard TM 58 Bosutinib 58 Contaminated Heparin 58 Infected Patients 58 Relapsed Refractory 58 Orphan Diseases 58 Refractory Hodgkin Lymphoma 58 Vimpat R 58 Valiant Thoracic Stent Graft 58 Survival Rates 58 Avian Flu Vaccine 58 Increlex R 58 Cancer Therapies 58 Cardiovascular Monitoring 58 HeartMate ® 58 STRIDE PD 58 Glufosfamide 58 Treatment Reduces 58 Chronic Myeloid Leukemia 58 Prevent Stroke 58 Preclinical Study 58 Acute Migraine 58 Receives SFDA Approval 58 Orally Active 58 Potent Antiviral Activity 58 Meta Analysis 58 coronary stenting 58 methylnaltrexone bromide 58 Immunosuppression 58 Receives Patent 58 Boston Scientific Promus 58 Proves Successful 58 Coronary Revascularization 58 Parathyroid Hormone 58 ENDEAVOR II 58 Disease Modifying 58 Oral Cladribine 58 Bepreve TM 58 Vicriviroc 58 cobalt chromium stent 58 Diamyd Medical Diamyd 58 Placebo Controlled Trial 58 MitraClip 58 Rotary VAD 58 Pioglitazone 58 Uterine Fibroid Embolization 58 Intravesical 58 solifenacin succinate 58 Biphasic 58 Tiotropium 58 Anti Inflammatory Drugs 58 CardioPass 58 Diabetic Foot Ulcer 58 Microplasmin 58 Cardiac Resynchronization 58 Aryplase 58 Reconstructive Tissue Matrix 58 Hip Fractures 58 Multicenter Trial 58 Intraocular Lens 58 Clot Busting 58 Yondelis ® 58 Angiogenic 58 vertebral augmentation 58 Carotid Artery 58 Accelerated Partial Breast Irradiation 58 Dose Ranging 58 Arterial Disease 58 Nasal Spray 58 Orthopedic Implant 58 DuraHeart TM 58 Shows Promising 58 Soft Tissue 58 RNAi Therapeutics 58 Bypass Surgery 58 Stent Graft 58 Dual Wavelength 58 Ciclesonide 58 Cervical Plate 58 Betaferon R

Back to home page